Total Payments
$9,103
2024 Payments
$915.54
Companies
39
Transactions
487
Medicare Patients
1,935
Medicare Billing
$231,485
Payment Breakdown by Category
Food & Beverage$9,032 (99.2%)
Gifts$71.52 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,032 | 486 | 99.2% |
| Gift | $71.52 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,609 | 90 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,254 | 83 | $0 (2024) |
| Janssen Biotech, Inc. | $1,065 | 66 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $754.50 | 43 | $0 (2024) |
| Allergan, Inc. | $587.91 | 43 | $0 (2020) |
| GENZYME CORPORATION | $336.61 | 10 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $265.38 | 13 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $263.19 | 13 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $251.99 | 9 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $241.86 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $915.54 | 42 | Janssen Biotech, Inc. ($229.92) |
| 2023 | $736.13 | 29 | GENZYME CORPORATION ($153.72) |
| 2022 | $1,382 | 63 | ABBVIE INC. ($279.76) |
| 2021 | $1,440 | 72 | AbbVie Inc. ($268.11) |
| 2020 | $851.59 | 55 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($232.45) |
| 2019 | $1,135 | 78 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($217.79) |
| 2018 | $1,503 | 84 | AbbVie, Inc. ($333.90) |
| 2017 | $1,140 | 64 | Valeant Pharmaceuticals North America LLC ($251.99) |
All Payment Transactions
487 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: EXALT_ENDO | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Gastroenterology | ||||||
| 10/25/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Immunology | ||||||
| 10/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Immunology | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: GI COLON PREP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 693 | 752 | $318,011 | $86,039 |
| 2022 | 13 | 438 | 474 | $214,326 | $54,060 |
| 2021 | 10 | 379 | 392 | $126,703 | $44,446 |
| 2020 | 12 | 425 | 438 | $138,706 | $46,941 |
Total Patients
1,935
Total Services
2,056
Medicare Billing
$231,485
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 159 | 165 | $67,671 | $23,496 | 34.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 50 | 50 | $37,126 | $10,240 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 52 | $9,300 | $5,488 | 59.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 82 | $18,184 | $5,157 | 28.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 68 | 69 | $40,735 | $4,942 | 12.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $8,850 | $4,844 | 54.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $6,600 | $4,274 | 64.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 49 | 49 | $25,736 | $4,273 | 16.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $17,570 | $4,170 | 23.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 20 | 20 | $11,200 | $3,825 | 34.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $26,230 | $3,597 | 13.7% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 12 | 12 | $10,106 | $3,297 | 32.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 24 | $3,340 | $2,386 | 71.4% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 13 | $13,123 | $2,040 | 15.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $4,944 | $1,596 | 32.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 13 | 13 | $6,554 | $1,323 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,590 | $693.51 | 43.6% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 14 | 14 | $9,152 | $397.42 | 4.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 67 | $32,301 | $10,820 | 33.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 48 | 48 | $35,253 | $10,084 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 61 | 61 | $9,150 | $5,186 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 47 | $9,400 | $4,792 | 51.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $22,204 | $3,692 | 16.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $33,497 | $3,374 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $4,600 | $3,212 | 69.8% |
About Dr. Shahram Javaheri, M.D
Dr. Shahram Javaheri, M.D is a Gastroenterology healthcare provider based in Mission Viejo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497861439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shahram Javaheri, M.D has received a total of $9,103 in payments from pharmaceutical and medical device companies, with $915.54 received in 2024. These payments were reported across 487 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,032).
As a Medicare-enrolled provider, Javaheri has provided services to 1,935 Medicare beneficiaries, totaling 2,056 services with total Medicare billing of $231,485. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Mission Viejo, CA
- Active Since 08/22/2006
- Last Updated 08/04/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1497861439
Products in Payments
- XIFAXAN (Drug) $907.98
- STELARA (Biological) $791.27
- LINZESS (Drug) $603.07
- DUPIXENT (Biological) $481.42
- Humira (Biological) $437.66
- ZENPEP (Drug) $385.65
- ZEPOSIA (Drug) $365.14
- OCALIVA (Drug) $251.10
- TRULANCE (Drug) $249.73
- ENTYVIO (Biological) $249.26
- UCERIS (Drug) $247.56
- GATTEX (Drug) $195.56
- Creon (Drug) $189.14
- TREMFYA (Drug) $181.29
- Linzess (Drug) $170.69
- INJECTAFER (Drug) $167.86
- RINVOQ (Biological) $149.35
- HUMIRA (Biological) $143.50
- Entyvio (Biological) $143.23
- Da Vinci Surgical System (Device) $139.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Mission Viejo
Ahmad Shaban, Md, MD
Gastroenterology — Payments: $17,743
Gastroenterology $17,743
Jack Feng, M.d, M.D
Gastroenterology — Payments: $17,051
Gastroenterology $17,051
Dr. Elmer Chang, M.d, M.D
Gastroenterology — Payments: $15,519
Gastroenterology $15,519
Dr. Nader Mirhoseni, M.d, M.D
Gastroenterology — Payments: $11,402
Gastroenterology $11,402
Michael Santoro, M.d, M.D
Gastroenterology — Payments: $10,955
Gastroenterology $10,955
Dr. Ronald Adamany, M.d, M.D
Gastroenterology — Payments: $9,312
Gastroenterology $9,312